Breast Cancer

Title Average Ratingsort ascending
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? 96.67%
Psorinum, the anti cancer miracle from India. 92.73%
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. 90.00%
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potent 90.00%
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, 90.00%
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. 90.00%
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. 90.00%
Clinical Investigations on Ukrain 90.00%
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. 90.00%
Is it time to test metformin in breast cancer clinical trials? 90.00%
The present state of antineoplaston research (1) 90.00%
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell 90.00%
Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy 90.00%
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. 90.00%
71 year old woman. Breast cancer with bone metastasis 90.00%
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti 90.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 90.00%
61 year old woman, Breast cancer with lymph, and lung metastasis 90.00%
GcMAF-The cancer revolution from Japan 87.33%
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. 85.00%
Todoxin, the immune stimulant from Serbia 84.44%
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. 80.00%
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse 80.00%
The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases. 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. 80.00%
Possible association between nanobacteria and malignant microcalcifications in breast cancer. 80.00%
A lipoxygenase inhibitor in breast cancer brain metastases. 80.00%
Metformin induces unique biological and molecular responses in triple negative breast cancer cells. 80.00%
Response of brain metastases from breast cancer to megestrol acetate: a case report. 80.00%
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m 80.00%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) 80.00%
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort 80.00%
The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. 80.00%
82 year old woman. Breast cancer with lymph and bone metastasis. 80.00%
Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor–Positive and Hormone Receptor–Negative Breast Cancer 80.00%
Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast ca 80.00%
Metformin in the treatment of Cancer 77.00%
Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer..... 75.00%
Cancer Psychotherapy according to Dr. Frederick B Levenson 73.33%
Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. 70.00%
Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. 70.00%
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic bre 70.00%
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). 70.00%
Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression. 70.00%
Effect of metronomic use of zoledronic acid (ZOL) on antitumor and antiosteoclastic effects in breast cancer patients with bone 70.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo 70.00%
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer 70.00%
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial 70.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can 63.33%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
SWOG 0012, a randomized phase III comparison of standard doxorubicin (A) and cyclophosphamide (C) followed by weekly paclitaxel 60.00%
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer 60.00%
CECs, CEPs and CTCs for prediction of response in patients with advanced breast cancer (ABC) receiving metronomic vinorelbine. 60.00%
Multicenter phase II study of temozolomide therapy for brain metastasis in patients with malignant melanoma, breast cancer...... 60.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 60.00%
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer with metronomic UFT + CP 60.00%
Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare 60.00%
Removed from Pubmed because of suspicion of scientific fraud: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). 55.00%
Adjuvante simultane Mistel-/Chemotherapie bei Mammakarzinom – Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit 50.00%
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy 50.00%
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line 50.00%
Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolera 50.00%
WITHDRAWN: Ovarian ablation for early breast cancer. 50.00%
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. 50.00%
A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients............... 50.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of non 50.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... 50.00%
Melatonin 45.00%
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer. 40.00%
A phase I study of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer. 40.00%
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. 30.00%
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer........ 0.00%
WITHDRAWN: Multi-agent chemotherapy for early breast cancer. 0.00%
Breast Cancer Treatment 0.00%
A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer. 0.00%